Picture of COSCIENS Biopharma logo

CSCI — COSCIENS Biopharma News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Aeterna Zentaris Reports Q2 Rev Negative $0.2 Mln

Aug 3 (Reuters) - Aeterna Zentaris Inc  AEZS.TO :
    * AETERNA ZENTARIS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND RECENT HIGHLIGHTS
    * AETERNA ZENTARIS INC - TOTAL REVENUE FOR THREE-MONTH
PERIOD
ENDED JUNE 30, 2022 WAS NEGATIVE $0.2 MILLION

Source text for Eikon:  ID:nGNX9brz0b 
Further company coverage:  AEZS.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on COSCIENS Biopharma

See all news